BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21106306)

  • 21. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation.
    Vicini F; Arthur D; Wazer D; Chen P; Mitchell C; Wallace M; Kestin L; Ye H
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):977-84. PubMed ID: 20510540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of leeds 10-year single-center brachytherapy experience.
    Henry AM; Al-Qaisieh B; Gould K; Bownes P; Smith J; Carey B; Bottomley D; Ash D
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):50-6. PubMed ID: 20005453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
    ; Frank SJ; Arterbery VE; Hsu IC; Abdel-Wahab M; Ciezki JP; Hahn NM; Mohler JL; Moran BJ; Rosenthal SA; Rossi CJ; Yamada Y; Merrick G
    Brachytherapy; 2011; 10(5):357-62. PubMed ID: 21497562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.
    Erickson BA; Bittner NH; Chadha M; Mourtada F; Demanes DJ
    Brachytherapy; 2017; 16(1):75-84. PubMed ID: 28109634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Brachytherapy for prostate carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):87-91. PubMed ID: 15920966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiation.
    Merrick GS; Butler WM; Lief JH; Galbreath RW; Adamovich E
    Cancer J; 2002; 8(4):322-7. PubMed ID: 12184410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
    Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
    Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation.
    Ohashi T; Yorozu A; Saito S; Momma T; Toya K; Nishiyama T; Yamashita S; Shiraishi Y; Shigematsu N
    Radiother Oncol; 2013 Nov; 109(2):241-5. PubMed ID: 24183866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources.
    Devlin PM; Gaspar LE; Buzurovic I; Demanes DJ; Kasper ME; Nag S; Ouhib Z; Petit JH; Rosenthal SA; Small W; Wallner PE; Hartford AC
    Brachytherapy; 2017; 16(6):1083-1090. PubMed ID: 28988661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy.
    Hakenberg OW; Wirth MP; Hermann T; Alken P; Kovacs G; Müller RP; Ahlemann L; Schalkhäuser K
    Urol Int; 2003; 70(1):15-20. PubMed ID: 12566809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
    Michalski JM; Roach M; Merrick G; Anscher MS; Beyer DC; Lawton CA; Lee WR; Pollack A; Rosenthal SA; Vijayakumar S; Carroll PR
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):667-72. PubMed ID: 19386445
    [No Abstract]   [Full Text] [Related]  

  • 32. Isotope selection for patients undergoing prostate brachytherapy.
    Cha CM; Potters L; Ashley R; Freeman K; Wang XH; Waldbaum R; Leibel S
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):391-5. PubMed ID: 10487561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
    Kollmeier MA; Stock RG; Stone N
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):645-53. PubMed ID: 14529768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In regard to the American Brachytherapy Society recommendations for 103palladium brachytherapy. Beyer et al. IJROBP 2000;47:273-275.
    King P; Anderson RS
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):899. PubMed ID: 11265655
    [No Abstract]   [Full Text] [Related]  

  • 36. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.
    Yu Y; Anderson LL; Li Z; Mellenberg DE; Nath R; Schell MC; Waterman FM; Wu A; Blasko JC
    Med Phys; 1999 Oct; 26(10):2054-76. PubMed ID: 10535622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
    Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
    Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standards, options and recommendations for the practice of external radiotherapy and brachytherapy in oncology. National Federation of Centers for the fight against Cancer].
    Bey P; Gaboriaud G; Peiffert D; Aletti P; Cosset JM
    Bull Cancer; 1995 Oct; 82(10):811-22. PubMed ID: 8535008
    [No Abstract]   [Full Text] [Related]  

  • 39. Imaging opportunities in radiation oncology.
    Balter JM; Haffty BG; Dunnick NR; Siegel EL;
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):342-7. PubMed ID: 20800378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy.
    Shah JN; Wuu CS; Katz AE; Laguna JL; Benson MC; Ennis RD
    Cancer J; 2006; 12(4):289-97. PubMed ID: 16925973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.